Market Access Strategy
Market Access Strategy
Market Access Strategy services, offering expert advisory boards, market and competition assessment, HTA road mapping, and for projects in several therapeutic areas, e.g., oncology, orphan drugs, diabetes and metabolic diseases, respiratory diseases, drug dependency, ophthalmology.
Example of previous projects
Hospital payment structure for an orphan oncology drug. Strategy development for a HTA, funding and pricing, including analogue case studies.
Evaluating the market access landscape for a new breast cancer treatment in the Nordics, including advice for a commercial oncology structure.
Funding opportunities for an ICU inhalation product in Europe. Identification of the hurdles and a proposal of mitigations.
Strategy based on an in-depth analysis of the funding structures and payment incentives for an ophthalmology product in the Nordics.
